Name: Johnson & Johnson vaccine: CDC panel votes 10-4 to lift suspension amid blood clot concerns
Uploaded: 2021-04-23T22:44:53Z
Duration: 3 min 3 s
Description: A committee with the U.S. Centers for Disease Control and Prevention on Friday recommended resuming the use of Johnson & Johnson’s COVID-19 vaccine, despite a very rare risk of blood clots.

Loading Video…

This browser does not support the Video element.

Johnson & Johnson vaccine: CDC panel votes 10-4 to lift suspension amid blood clot concerns

A committee with the U.S. Centers for Disease Control and Prevention on Friday recommended resuming the use of Johnson & Johnson’s COVID-19 vaccine, despite a very rare risk of blood clots.

Posted April 23, 2021 5:44pm CDT